Academic Innovation Session!!! – Novel Formulation Strategies Conference, Hyderabad: 23-24 May 2019

“Novel Formulation Strategies” is a unique, Pharma Industry focused, event designed to discuss novel strategies for pharmaceutical product development. India is the largest manufacturer of generic medicines globally and therefore drug formulation strategies need to be updated and discussed in order to successfully develop novel formulations. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.

Academic Innovation Session: In this event a special session has been designated towards Academic Innovations. A large number of Pharmaceutical Scientists in Academic Institutions have been working on formulation development. In this session we aim to present selected Academic Formulation related Innovations which might have importance in industry but could otherwise go unnoticed by industry scientists. This session will be open to Regular PhD Research Scholars only. Each presentation will be for 5-10 minutes duration only and will be adjudged by the industry scientists. The presentation providing best innovation and/or solution with direct application in pharmaceutical industry will be awarded Rs 5100/-during the closing ceremony of the conference. In addition the 2nd and 3rd position presentations will be awarded Rs 3100/- and Rs 2100/- respectively. Faculty (Registered Indian Delegate) presenting the innovation will not be eligible for the award but will be allowed to present.

The last date for submission of abstracts for presentation in this session is upto April 27, 2019. The selected presenters will be required to complete the registration process latest by April 29, 2019. Those not registering by the said date will lose the opportunity to present and the same will be offered to the next candidate.For detailed information about speakers and presentations, please contact Ms Pooja Sharma, Email:, or Call +91 7696325050 or WhatsApp: 9041725050.

Call for Papers

If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!

Oral Submission Deadline: 10th May 2019

Agenda Topics

  • Bioequivalence and Biowaiver Strategies
    • BCS 1-3 Oral Solid Dosage Forms
    • Oral Extended/Modified Release Formulations
  • Drug Delivery Systems
    • Lipid based Systems
    • Permeation Enhanced Topical Preparations
    • Spray Systems for Nasal Preparations
  • Formulation Development Approaches
    • Difficult to Formulate FDC
    • QbD Approaches
    • Taste Masking of Pediatric PFOS Dosage Forms
    • Temperature/Moisture Sensitive Drugs
    • Water Insoluble Drugs for IV Injections
  • Innovations for US/Europe Markets
    • 505(b)(2), ANDA
  • Solubility and Oral Bioavailability Enhancement
  • Stability Issues with Formulations and Complex Generics

Exhibition & Registration

Farheen Zainab

Cell: 7696125050, 7696525050

WhatsApp: 9041725050

Confirmed Speakers to date

Sandhya Shenoy, Associate Vice President, FDC Ltd, India

Yogeshwar Bachhav, Associate Director Pharmaceutical Development, AiCuris Anti-infective Cures GmbH, Germany

Salil Desai, Senior Principal Investigator, Biocon Bristol-Myers Squibb Research Center, India

Vinay Patil, Associate Director, Dr. Reddy\’s Laboratories, India

Madhavan P Nair, Distinguished Professor and Head of the Department, Florida International University, USA

Sumedha Nadkar, Senior Director and Site Head, Perrigo Laboratories India Pvt. Ltd, India

Ashish Gogia, EVP R&D, Medreich Limited, India

Aravinda Babu Pedamullu, Retired Sr. Vice President, Wockhardt/Consultant to Pharma Industries, India

Invited Speakers

Satish Kumar Singh, Head, Moderna Therapeutics, USA

Damon C. Smith, President and CEO, Altus Formulation, Canada

Apply Now

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *